Mathematical modelling leads to a better understanding of prostate cancer
3D model depicts processes such as tumour growth
Prostate cancer is the most common cancer in men. However, the mechanisms of tumour development, particularly the development of aggressive tumours, are still largely unclear in prostate cancer and other malignant tumours for two reasons: Firstly, tumours are often only discovered when they have already reached a considerable size. The time span between the development of the tumour and the diagnosis, which can be 10 to 30 years, is therefore not taken into account. Secondly, state-of-the-art methods such as next-generation sequencing (NGS), which make it possible to comprehensively characterize the tumour at subclone level, are costly and extremely complex to evaluate. For these reasons, only a few tumours worldwide have so far been examined in this way.
“Our study shows that we can use mathematical modelling to address important, previously unanswered questions about the development of malignant tumours and thus gain clinically relevant insights. Our model is universally applicable and can also be used for other malignant tumour types,” explained senior physician and co-leader of the study, Dr Yuri Tolkach from the Institute of General Pathology and Pathological Anatomy at University Hospital Cologne.
“With our new model, we can reproduce the complex spatial structure of a prostate tumour, which grows like a root system in the tissue," explained postdoc and co-leader of the study, Dr Florian Kreten, who previously worked at the Institute for Applied Mathematics at the University of Bonn. He added: “Conventional mathematical models of tumour growth and evolution could not be applied to these structures. From a mathematical point of view, the underlying growth mechanism is extremely fascinating and has raised a number of new questions. Our work shows how biology can inspire mathematical research.” In future, the scientists hope to be able to further develop the models and to include the interaction between the tumour and the immune system.
Original publication
Original publication
Florian Kreten, Reinhard Büttner, Martin Peifer, Christian Harder, Axel M. Hillmer, Nima Abedpour, Anton Bovier, Yuri Tolkach; "Tumor architecture and emergence of strong genetic alterations are bottlenecks for clonal evolution in primary prostate cancer"; Cell Systems
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.